Brianna Grider, PA
Physician Assistant · Bowling Green, KYNPI 1093187304
Payments from drug & device makers
Across 682 payments — averaging $19.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$2K
- Regeneron Healthcare Solutions, Inc.$1K
- E.r. Squibb & Sons, L.L.C.$1K
- Galderma Laboratories, L.p.$884
- Lilly USA, LLC$759
- plus $5K from 27 others
What the payments were for
- Food & beverage$12,24094%
- Education$7336%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 140 | $1,862 |
| Johnson & Johnson(2 entities) | 94 | $1,693 |
| Regeneron Healthcare Solutions, Inc. | 48 | $1,468 |
| E.r. Squibb & Sons, L.L.C. | 48 | $1,031 |
| Galderma Laboratories, L.p. | 48 | $884 |
| Lilly USA, LLC | 30 | $759 |
| UCB, Inc. | 46 | $721 |
| Novartis | 46 | $686 |
| Sanofi | 23 | $570 |
| Amgen | 27 | $532 |
| Sun Pharmaceutical Industries Inc. | 20 | $514 |
| LEO Pharma Inc. | 25 | $460 |
| Dermavant Sciences, Inc. | 12 | $374 |
| Pfizer | 16 | $286 |
| Arcutis Biotherapeutics, Inc. | 19 | $248 |
| Incyte Corporation | 3 | $185 |
| Mallinckrodt Hospital Products Inc. | 5 | $160 |
| Boehringer Ingelheim | 5 | $100 |
| Kyowa Kirin, Inc. | 1 | $55 |
| Organon | 7 | $49 |
| Mylan Institutional Inc. | 2 | $45 |
| Biofrontera Inc. | 4 | $43 |
| EPI Health, LLC | 2 | $38 |
| ANI Pharmaceuticals, Inc. | 2 | $33 |
| Avita Medical Americas, LLC | 1 | $28 |
| Mayne Pharma Commercial LLC | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $22 |
| Krystal Biotech Inc | 1 | $19 |
| VYNE Pharmaceuticals Inc. | 1 | $16 |
| Verrica Pharmaceuticals Inc. | 1 | $14 |
| Cipher Pharmaceuticals US LLC | 1 | $14 |
| Fresenius Kabi USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,973 in reported general payments places this provider in the 95th percentile of 1,448 physician assistant providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 42 | $862,207 |
| Dupixent PenDupilumab | 147 | $543,901 |
| RinvoqUpadacitinib | 49 | $310,302 |
| Humira(Cf) PenAdalimumab | 45 | $305,446 |
| OtezlaApremilast | 12 | $57,211 |
| Dupixent SyringeDupilumab | 14 | $55,773 |
| AdbryTralokinumab-Ldrm | 12 | $45,147 |
| Fluorouracil | 40 | $3,067 |
| Ketoconazole | 183 | $2,584 |
| Betamethasone Valerate | 72 | $2,063 |
| Tacrolimus | 23 | $1,887 |
| Clindamycin Phosphate | 31 | $1,588 |
| Clobetasol Propionate | 20 | $1,573 |
| Fluocinonide | 38 | $1,416 |
| Hydroxychloroquine Sulfate | 40 | $1,267 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $1,862 | $310,30249 claims |
| AmgenOtezla | $532 | $57,21112 claims |
| LEO Pharma Inc.Adbry | $460 | $45,14712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,448 physician assistant providers in Kentucky.
Other physician assistant in Bowling Green
- Seth KingBowling Green$91K
- Cameron CollierBowling Green$8K
- Brandice HarrisonLexington$745K
- Lauren MeadeLexington$656K
- Melissa DavisLouisville$362K
- Kara MuddLouisville$98K
- Marty MullinsHazard$63K
- Lauri GarnerVersailles$33K
- Robert TatumLouisville$29K
- Michelle JonesLexington$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.